These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36112199)

  • 41. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
    Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Characteristics of Anti-
    Zhang S; Yang Y; Liu W; Li Z; Li J; Zhou D
    Front Immunol; 2022; 13():857443. PubMed ID: 35837405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cryptococcal Encephalitis Complicating Anti-N-methyl-D-aspartate Receptor Encephalitis in an Immunosuppressed Patient].
    Liu D; Xu H; Yi F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):417-420. PubMed ID: 32616142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and Magnetic Resonance Imaging Outcome Predictors in Pediatric Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Bartels F; Krohn S; Nikolaus M; Johannsen J; Wickström R; Schimmel M; Häusler M; Berger A; Breu M; Blankenburg M; Stoffels J; Hendricks O; Bernert G; Kurlemann G; Knierim E; Kaindl A; Rostásy K; Finke C
    Ann Neurol; 2020 Jul; 88(1):148-159. PubMed ID: 32314416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral gray matter volume changes in patients with anti-N-methyl-D-aspartate receptor encephalitis: A voxel-based morphometry study.
    Long Q; Lv Z; Zhao J; Shi K; Li C; Fan B; Zheng J
    Front Neurol; 2022; 13():892242. PubMed ID: 35959389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Serum Anti-Thyroid Antibodies: A Case Report and Literature Review.
    Matera E; Gabellone A; Petruzzelli MG; Marzulli L; Furente F; Margari L
    Am J Case Rep; 2021 May; 22():e931104. PubMed ID: 33999913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulated CD40 and CD40 ligand expression in anti-N-methyl-d-aspartate receptor encephalitis.
    Ma X; Chen C; Fang L; Zhong X; Chang Y; Li R; Wang Y; Hu X; Qiu W; Shu Y
    J Neuroimmunol; 2022 Jan; 362():577762. PubMed ID: 34839148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia.
    Savage SA; Irani SR; Leite MI; Zeman AZ
    J Neuroimmunol; 2019 Feb; 327():41-43. PubMed ID: 30686545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive deficits following anti-NMDA receptor encephalitis.
    Finke C; Kopp UA; Prüss H; Dalmau J; Wandinger KP; Ploner CJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):195-8. PubMed ID: 21933952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-cell transcriptomics reveals cell type-specific immune regulation associated with anti-NMDA receptor encephalitis in humans.
    Jiang Y; Dai S; Jia L; Qin L; Zhang M; Liu H; Wang X; Pang R; Zhang J; Peng G; Li W
    Front Immunol; 2022; 13():1075675. PubMed ID: 36544777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-N-methyl-D-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction.
    Nazif TM; Vázquez J; Honig LS; Dizon JM
    Europace; 2012 Aug; 14(8):1188-94. PubMed ID: 22345374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term neuropsychological outcomes in children and adolescents after cardiac arrest.
    van Zellem L; Buysse C; Madderom M; Legerstee JS; Aarsen F; Tibboel D; Utens EM
    Intensive Care Med; 2015 Jun; 41(6):1057-66. PubMed ID: 25894622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis.
    Nosadini M; Thomas T; Eyre M; Anlar B; Armangue T; Benseler SM; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK; Irani SR; Dalmau J; Lim M; Dale RC
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological functioning following surgery for pediatric low-grade glioma: a prospective longitudinal study.
    Heitzer AM; Raghubar K; Ris MD; Minard CG; Gragert MN; Stancel HH; Orobio J; Xue J; Whitehead W; Okcu MF; Chintagumpala M; Kahalley LS
    J Neurosurg Pediatr; 2020 Mar; 25(3):251-259. PubMed ID: 31812134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognosis of late-onset anti-N-methyl-D-aspartate receptor encephalitis in China.
    Sun Y; Ren G; Ren J; Shan W; Han X; Lian Y; Wang T; Wang Q
    Acta Neurol Scand; 2022 Apr; 145(4):449-455. PubMed ID: 34918336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electroencephalography characteristics to predict one-year outcomes in pediatric anti-NMDA receptor encephalitis.
    Lin J; Elkins K; Bhalla S; Gedela S; Kheder A; Zhang G; Loerinc L; Blackwell L; Howarth R; Gombolay G
    Epilepsy Res; 2021 Dec; 178():106787. PubMed ID: 34715485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spontaneous recovery of memory functions in an untreated case of anti NMDAR encephalitis - a reason to maintain hope.
    McIvor K; Moore P
    Clin Neuropsychol; 2017 Jan; 31(1):289-300. PubMed ID: 27762163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical course of recovery from cognitive dysfunction in a patient with anti-N-methyl-D-aspartate receptor encephalitis].
    Asai C; Morinaga A; Yamamoto K; Imamura T
    Brain Nerve; 2014 Oct; 66(10):1219-24. PubMed ID: 25296876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports.
    Maggio MC; Mastrangelo G; Skabar A; Ventura A; Carrozzi M; Santangelo G; Vanadia F; Corsello G; Cimaz R
    J Med Case Rep; 2017 Aug; 11(1):225. PubMed ID: 28810906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.